IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Innovation
Eduard Batlle, 2014 “Vanguardia de la Ciencia” Award finalist
Innovation
“We were the first Spanish biotechnology company to use equity crowdfunding”, Giralt/Tarragó
Innovation
“Spark”, the project led by Iproteos to combat schizophrenia
Innovation
Positive venoms for the mind
Visiting students during a practical session at IRB Barcelona labs.
Innovation
“A Future in Biomedicine”, an initiative to promote scientific vocation among university students
The Spark project seeks to develop a drug to treat schizophrenia (Photo: Iproteos & G. Battista)
Innovation
«Spark», a new public-private project created to develop a drug to fight the cognitive impairment associated with schizophrenia
Innovation
Who pays for science?
Innovation
“We can help to predict the negative effects of drugs that have not yet been studied”
Scheme of photoswitchable inhibition protein-protein interaction (PPI). / Pau Gorostiza et al.
Innovation
A further step towards light-controlled drugs

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog